New Drugs, Medicines & Therapies Products Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Product Browse All Products Pfizer RxPathways connects eligible patients to a range of assistance programs that...
pipeline research sites products how drugs are made branded vs. generic biologics & biosimilars commitment to quality global supply manufacturing sites medicine safety health literacy treatment choices partnering with patients tips for patients reporting adverse events counterfeiting product safety product list...
Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere. To Our Investors Why Invest
Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.To Our Investors Why Invest Financial Reports Events and Presentations Stock Information...
Product Pipeline Research Sites Products How Drugs Are Made Branded vs. GenericLearn the difference Biologics & BiosimilarsCures found in nature Commitment to QualityMaintaining the highest standards Global SupplyStrategic manufacturing locations Manufacturing SitesWhere medicine is made in the U.S. Medicine...
The article reports on two agreements signed by pharmaceutical firm Pfizer at finding new markets for drugs in its pipeline. Caliper Life Sciences Inc. will perform in vivo drug-profiling experiments for compounds in Pfizer's pipeline to determine whether new indications can be pursued for them. ...
Though the headlines and sentiment seem dire, that pessimism is largely rooted in investors’ collective view that sees a glass as half-empty rather than half-full. Pfizer’s got a quietly potent pipeline, though, with a mix of already-approved and new drugs closer to wrapping up clinical tr...
"While we see several assets in Pfizer's pipeline (particularly in oncology) that could make the story more interesting, we believe that further advancement ... will be necessary to change the current narrative on shares which would primarily occur 2026+," JP Morgan analyst Chris Schott wrote ...
We're elevating our breakthroughs in a bold new way on Pfizer.com. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development!
All the sales intelligence you need on Pfizer Inc in one solution. Register your interest Save hours of research time with a comprehensive Sales Intelligence Solution. Understand how Pfizer Inc fits into your total addressable market and Ideal Customer Profile. ...